Precipio, Inc. - Common Stock (PRPO)

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces third-quarter financial results for the quarter ending September 30, 2026.

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2026 shareholder update call on November 10th, 2026, at 5:00 PM ET.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Specialty Cancer Diagnostics Company Focused on Creating Cutting-Edge Products for Laboratories Through a Unique Business Model